Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 305.4036
- Book/Share 61.2567
- PB 1.2335
- Debt/Equity 1.0691
- CurrentRatio 0.8034
- ROIC 0.0353
- MktCap 95619125411.0
- FreeCF/Share 3.7757
- PFCF 20.004
- PE 21.0646
- Debt/Assets 0.3202
- DivYield 0.0353
- ROE 0.0595
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS Health to hold third quarter 2025 earnings conference call
Published: September 30, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, October 29 th, 2025, at 8:00 a.m.
Read More
CVS Health Gains as Revenue Grows, Dividend Remains Strong
Published: September 25, 2025 by: MarketBeat
Sentiment: Positive
One of the best ways for any investor to lock in additional portfolio upside is to start exploring areas where few others are willing to venture, especially when those are the least popular ones in the entire market.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
CVS Health Drives Drug Affordability by Promoting Competition
Published: September 23, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS strengthens Caremark's PBM edge with formulary shifts, new partnerships and cost-saving wins for clients.
Read More
CVS unit Omnicare files for bankruptcy to resolve litigation
Published: September 22, 2025 by: Reuters
Sentiment: Negative
Omnicare, a subsidiary of health insurer CVS Health , said on Monday it has filed for bankruptcy to resolve issues related to its recent litigation in the U.S. District Court for the Southern District of New York.
Read More
Omnicare Initiates Voluntary Chapter 11 Process
Published: September 22, 2025 by: PRNewsWire
Sentiment: Neutral
Company Intends to Use Process to Implement a Standalone Restructuring or Sale Strategy Remains Focused on Delivering Safe and Reliable Pharmacy Services to All Customers WOONSOCKET, R.I. , Sept. 22, 2025 /PRNewswire/ -- Omnicare, LLC, a subsidiary of CVS Health (NYSE: CVS), today announced it has initiated a voluntary court-supervised Chapter 11 process to resolve issues related to its recent litigation in the U.S. District Court for the Southern District of New York.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS trims its outlook as Oak Street faces rising medical costs, but new leadership and tech upgrades aim for steady growth.
Read More
CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS shows revenue growth and raised guidance, while EVH faces revenue declines but pursues oncology deals and efficiency gains.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.
Read More
Stock Of The Day: Is CVS Headed Higher?
Published: September 09, 2025 by: Benzinga
Sentiment: Positive
CVS Health Corporation CVS is trading higher on Tuesday. This follows yesterday's sell-off of almost 5%.
Read More
Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest?
Published: September 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
CVS Health Trades Cheaper Than Industry: How to Play the Stock?
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' diversified model, digital push and Aetna stabilization highlight a compelling investment story.
Read More
Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy
Published: September 02, 2025 by: 24/7 Wall Street
Sentiment: Positive
Healthcare investing has felt like walking through quicksand this year.
Read More
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure
Published: September 02, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' Health Care Benefit arm shines in Q2, driven by government plans, even as ACA exit and utilization pressures weigh.
Read More
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
Published: September 01, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Cramer Loves These Dividend Stocks
Published: September 01, 2025 by: 24/7 Wall Street
Sentiment: Positive
Key Points Jim Cramer's Mad Money offers insights valuable to income investors, despite his broader focus on growth.
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
CVS vs. HQY: Which Stock Is the Better Value Option?
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?
Read More
CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.
Read More
CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.
Read More
The Big 3: LLY, BA, CVS
Published: August 22, 2025 by: Schwab Network
Sentiment: Positive
Dan Deming considers Friday's trading action after Jerome Powell's Jackson Hole speech "remarkable." On stocks he's watching ahead, he expects Eli Lilly (LLY) to rebound off a significant sell-off, Boeing (BA) to soar on its financial recovery and aircraft backlog, and CVS Health (CVS) to capture more market share in the pharma space.
Read More
CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
Read More
4 Value Stocks Every Investor Should Hold in Volatile Times
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Positive
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.
Read More
Value Investing: 5 Undervalued Stocks Worth Adding to Your Portfolio
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Positive
StoneCo, CVS Health, KT, KB Financial and USANA Health stand out as undervalued picks with low P/B ratios and solid growth prospects.
Read More
Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
Published: August 20, 2025 by: Reuters
Sentiment: Negative
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
Read More
CVS Health upgraded by UBS on strong execution, margin improvement
Published: August 18, 2025 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) has been upgraded by UBS analysts who cited greater confidence in the company's recovery trajectory and multiple levers for earnings growth. The analysts upped their rating to ‘Buy' from ‘Neutral' and raised their price objective to $79 from $67, implying upside from its share price on Monday afternoon of about $70.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000